Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a sele…
Biotechnology
US, San Francisco [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Olema Pharmaceuticals, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDOlema Pharmaceuticals, Inc. can't present revenue by segment